47 results on '"Kain, Kevin C."'
Search Results
2. Intestinal Injury in Ugandan Children Hospitalized With Malaria
3. Soluble Urokinase-Type Plasminogen Activator Receptor as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria
4. Prognostic Accuracy of Soluble Triggering Receptor Expressed on Myeloid Cells (sTREM-1)-based Algorithms in Febrile Adults Presenting to Tanzanian Outpatient Clinics
5. Fever in returning travellers and migrants: disease severity markers to improve triage and management
6. Single-dose radical cure for Plasmodium vivax
7. Spectrum of illness in migrants to Canada: sentinel surveillance through CanTravNet
8. Plasmodium falciparum-CD36 Structure-Function Relationships Defined by Ortholog Scanning Mutagenesis
9. Estradiol Levels Are Altered in Human Immunodeficiency Virus–Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy
10. Maternal Dietary L-Arginine and Adverse Birth Outcomes in Dar es Salaam, Tanzania
11. Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria
12. Biomarkers of hypoxia, endothelial and circulatory dysfunction among climbers in Nepal with AMS and HAPE: a prospective case–control study
13. Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria
14. Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated With Increased Mortality
15. Imported Plasmodium vivax Malaria ex Pakistan
16. A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy
17. Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome
18. Adenosine Triphosphate Depletion of Erythrocytes Simulates the Phenotype Associated with Pyruvate Kinase Deficiency and Confers Protection againstPlasmodium falciparumIn Vitro
19. Use of Peroxisome Proliferator‐Activated Receptor γ Agonists as Adjunctive Treatment forPlasmodium falciparumMalaria: A Randomized, Double‐Blind, Placebo‐Controlled Trial
20. Rosiglitazone Modulates the Innate Immune Response toPlasmodium falciparumInfection and Improves Outcome in Experimental Cerebral Malaria
21. Environmental Hazards in Nepal: Altitude Illness, Environmental Exposures, Injuries, and Bites in Travelers and Expatriates
22. A Randomized, Placebo‐Controlled Trial of Rosiglitazone for HIV‐Related Lipoatrophy
23. HIV Immunosuppression and Antimalarial Efficacy: Sulfadoxine‐Pyrimethamine for the Treatment of Uncomplicated Malaria in HIV‐Infected Adults in Siaya, Kenya
24. Placental Chondroitin Sulfate A–Binding Malarial Isolates Evade Innate Phagocytic Clearance
25. Parasitic Central Nervous System Infections in Immunocompromised Hosts: Clarification of Malaria Diagnosis
26. Prospective Analysis of Parasitic Infections in Canadian Travelers and Immigrants
27. A Population-based Comparison between Travelers Who Consulted Travel Clinics and Those Who Did Not
28. Blood and Body Fluid Exposure as a Health Risk for International Travelers
29. Atovaquone/Proguanil: The Need for Family Protection
30. Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus
31. Inactivation ofPlasmodium falciparumby Photodynamic Excitation of Heme‐Cycle Intermediates Derived from δ‐Aminolevulinic Acid
32. CD36 Mediates the Phagocytosis ofPlasmodium falciparum–Infected Erythrocytes by Rodent Macrophages
33. Travel Patterns and Risk Behavior in Solid Organ Transplant Recipients
34. Furuncular Myiasis: A Simple and Rapid Method for Extraction of IntactDermatobia hominisLarvae
35. Ineffectiveness of the Current Strategy to Prevent Hepatitis A in Travelers
36. Nonpathogenic Protozoa: Laboratory Reporting Practices in Canada and the United States
37. Malaria Chemoprophylaxis in the Age of Drug Resistance. II. Drugs That May Be Available in the Future
38. Malaria Chemoprophylaxis in the Age of Drug Resistance. I. Currently Recommended Drug Regimens
39. Plasmodium falciparumMalaria in Laos: Chloroquine Treatment Outcome and Predictive Value of Molecular Markers
40. Plasmodium falciparum–Infected Erythrocytes and Oxidized Low‐Density Lipoprotein Bind to Separate Domains of CD36
41. Prophylactic Drugs for Malaria: Why Do We Need Another One?
42. Determination of Failure of Treatment of Plasmodium falciparum Infection by Using Polymerase Chain Reaction Single‐Strand Conformational Polymorphism Fingerprinting
43. Effects of Viral Hemorrhagic Fever Inactivation Methods on the Performance of Rapid Diagnostic Tests forPlasmodium falciparum
44. Imported Malaria: Prospective Analysis of Problems in Diagnosis and Management
45. Comparison of the ParaSight™-F test and the ICT Malaria Pf™ test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers
46. Evaluation of a non-isotopic polymerase chain reaction-based assay to detect and predict treatment failure of Plasmodium vivax malaria in travellers
47. Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.